ANGPT2 and breast cancer: This review summarizes the biology of VEGF and ANG2 signaling, mechanisms of vascular normalization, preclinical and clinical evidence of VEGF/ANG2 bispecific antibodies, and current and future therapeutic applications in breast cancer, highlighting their potential to enhance multimodal treatment efficacy and improve patient outcomes.